United Therapeutics Corporation (UTHR) Hits Fresh High: Is There Still Room to Run? [Yahoo! Finance]
United Therapeutics Corporation (UTHR)
Last united therapeutics corporation earnings: 4/29 06:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.unither.com/investor-relations
Company Research
Source: Yahoo! Finance
The stock hit a new 52-week high of $262.51 in the previous session. United Therapeutics has gained 19.3% since the start of the year compared to the 2.2% move for the Zacks Medical sector and the -6.2% return for the Zacks Medical - Drugs industry. What's Driving the Outperformance? The stock has an impressive record of positive earnings surprises, as it hasn't missed our earnings consensus estimate in any of the last four quarters. In its last earnings report on May 1, 2024, United Therapeutics reported EPS of $6.17 versus consensus estimate of $5.63. For the current fiscal year, United Therapeutics is expected to post earnings of $23.88 per share on $2.66 billion in revenues. This represents a 20.55% change in EPS on a 14.38% change in revenues. For the next fiscal year, the company is expected to earn $25.05 per share on $2.86 billion in revenues. This represents a year-over-year change of 4.87% and 7.26%, respectively. Valuation Metrics United Therapeutics may be at a 5
Show less
Read more
Impact Snapshot
Event Time:
UTHR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
UTHR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
UTHR alerts
High impacting United Therapeutics Corporation news events
Weekly update
A roundup of the hottest topics
UTHR
News
- United Therapeutics Co. (NASDAQ: UTHR) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.MarketBeat
- Here's Why United Therapeutics (UTHR) is a Strong Value Stock [Yahoo! Finance]Yahoo! Finance
- United Therapeutics Co. (NASDAQ: UTHR) had its price target raised by analysts at JPMorgan Chase & Co. from $280.00 to $300.00. They now have an "overweight" rating on the stock.MarketBeat
- United Therapeutics Co. (NASDAQ: UTHR) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.MarketBeat
- Pulmonary Arterial Hypertension Market To Reach USD 12.2 Billion By 2032 | DataHorizzon Research [Yahoo! Finance]Yahoo! Finance
UTHR
Earnings
- 5/1/24 - Beat
UTHR
Sec Filings
- 5/23/24 - Form 4
- 5/22/24 - Form 4
- 5/20/24 - Form 4
- UTHR's page on the SEC website